Commerzbank: Two Timetables, One Stock — UniCredit's Approval and RBC's Deferred Rate Bet

Commerzbank shares ended Wednesday's session at €37.82, and the reason for the softness is not what a casual observer might assume. The ECB's green light for UniCredit to push past the 30% threshold — and to keep building without any ceiling — only hit the wires after Xetra had already closed. The day's decline therefore cannot be read as the market's verdict on the approval. One finished trading day, one subsequent corporate announcement: the two belong in separate columns.

What the Permission Does and Doesn't Do

UniCredit confirmed it may now cross the 30% mark in Commerzbank and raise its stake without an upper limit. Once the remaining steps are complete, the Italian lender expects to hold roughly 50% of the voting rights — a position that would open the door to taking control.

That is a description of two different procedural stages. The regulatory clearance exists today; the anticipated voting position does not. UniCredit itself expects the outstanding regulatory processes and offer conditions to wrap up by year-end, a timeline echoed in press coverage on Wednesday. Until those steps are actually finished, the 50% figure remains a company projection rather than a completed state of affairs. The approval removes one supervisory obstacle — it does not substitute for execution.

RBC Moves First, and Only Slightly

A day earlier, on Tuesday, RBC Capital Markets had already nudged its price target for Commerzbank from €40 to €41, keeping its rating at "Sector Perform." Analyst Anke Reingen revised her estimates ahead of the quarterly report, citing higher interest rates as the driver.

The timing matters: the adjustment predates the ECB news and should not be read as a retrospective thumbs-up for it. Nor does a higher target amount to an upgrade — the sector-neutral stance is unchanged, and no buy recommendation accompanies the move.

The real caveat buried in RBC's note concerns sequencing. The firm expects the bulk of the rate benefit to materialize only after the third quarter under review. A higher target, in other words, is not a prediction that the next earnings release will showcase those gains in full.

November 5 as the Next Fixed Point

Commerzbank is scheduled to publish its third-quarter 2026 results on November 5 — the next hard data point for anyone tracking the operating story. Investors should keep two horizons distinct when that report lands: the quarter's reported figures and the later rate tailwind RBC is banking on are not the same thing. Reading the raised target as a signal for the imminent numbers misses that gap. The analyst note pairs a modestly higher valuation with patience on when the earnings effect actually shows up.

Two Clocks Running Side by Side

What emerges is a stock being assessed on two independent tracks. The first is operational — earnings, net interest income, the timing of rate-driven gains. RBC's revision speaks mainly to this track, and its message is one of deferred rather than immediate payoff.

The second is the control question. The ECB authorization has made UniCredit's path to a dominant stake more concrete, but whether and when that stake becomes the intended voting position still hinges on closing the remaining steps. An approval granted is not a takeover completed — and for now, that distinction is the one that matters most.